Most people don't have the time to thoroughly research cannabis stocks, nor the experience to know when to buy or sell - this is where CST comes in.
We give everyday traders the opportunity to look over the shoulder of an equities analyst with a passion for the cannabis sector.
Members of CST get daily analysis and access to a model portfolio so they can review cannabis investments like a pro.
Leading The Way
Michael Vodicka is a globally syndicated equity analyst with more than 20 years of experience in trading and investing. His research has been featured in some of the industry’s most respected publications.
He has been investing and leading investors in the cannabis sector since 2013. Now, Mr. Vodicka brings his expertise and guidance to the members of Cannabis Stock Trades.
The U.S. economy continues to recover from the COVID lockdown – and nowhere is this more apparent than in Las Vegas. Las Vegas has recently experienced a big uptick in visitors as consumers gain more confidence and emergency orders lift.
The Las Vegas economy should continue to recover in the coming weeks and months. Casinos are now operating at 100% capacity, and that should drive millions of new tourists into Sin City in the second half of the year.
The Las Vegas recovery is a big win for one of the largest cannabis companies in the U.S.
The U.S. cannabis industry has a powerful new ally – one of the largest and most influential tech companies ever. Not only does this tech goliath support federal cannabis legalization, but it will also invest millions lobbying Congress to make it happen.
Cannabis investors looking to buy low need to check out the biggest cannabis stock IPO of 2021.
An early industry leader valued at $1.7 billion just began trading on the Canadian Stock Exchange. And while this company is delivering crazy sales growth, shares have hardly moved since going public, making this a bargain opportunity in the cannabis sector. Continue “$1.7 Billion Cannabis Stock IPO: Buy or Pass?”